𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies

✍ Scribed by Radojka M. Savic; Daniël M. Jonker; Thomas Kerbusch; Mats O. Karlsson


Publisher
Springer
Year
2007
Tongue
English
Weight
305 KB
Volume
34
Category
Article
ISSN
1573-8744

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Pharmacokinetics of pafenolol in the rat
✍ Hans Lenneras; Carl G. Regårdh 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 559 KB

The pharmacokinetics of pafenolol, a highly selective /?,-adrenoceptor antagonist, have been studied in starved and unstarved rats. Separate groups received intravenous doses (0.3 and 3.0pmol kg-I) and oral doses (1 and 25pmol kg-I). The systemic clearance of pafenolol was constant in the dose range

Evaluation of different indirect measure
✍ L. F. Lacey; O. N. Keene; C. Duquesnoy; A. Bye 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 414 KB

As indirect measures of rate of drug absorption (metrics), maximum plasma concentration (C-) is confounded by extent of drug absorption and the time to reach C , , (t-) is a discrete variable, dependent on blood sampling frequency. Building on the work of Endrenyi et al., we have compared different

A pocket calculator program for pharmaco
✍ Denis F. Hochstrasser; Richard J. Fleck; J.Heyward Hull; Felix A. Sarubbi 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 591 KB

A pocket computer program has been designed to assist clinicians in the appropriate administration of most drugs exhibiting single compartment first-order elimination and either zero-order (intravenous infusions) or first-order (intramuscular and oral) absorption The program utilizes well-establishe

A rabbit model for sublingual drug deliv
✍ Dali, Manisha M. (author);Moench, Paul A. (author);Mathias, Neil R. (author);Ste 📂 Article 📅 2006 🏛 John Wiley and Sons Inc. 🌐 English ⚖ 109 KB

A rabbit model for investigating sublingual drug absorption was established yielding results consistent with clinical data reported in the literature. Using propranolol as a model compound the effect of formulation and dosing variables was explored as a means to characterize the limiting parameters